Bimonthly injections of ranibizumab for age-related macular degeneration

被引：1
|
作者：
Ilhan, Abdullah [1 ,5 ]
Tas, Ahmet [2 ]
Yolcu, Umit [3 ]
Gundogan, Fatih C. [4 ]
机构：
[1] Erzurum Mil Hosp, Dept Ophthalmol, Erzurum, Turkey
[2] Agri Mil Hosp, Dept Ophthalmol, Agri, Turkey
[3] Sarikamis Mil Hosp, Dept Ophthalmol, Kars, Turkey
[4] Gulhane Mil Med Acad, Dept Ophthalmol, Ankara, Turkey
[5] Erzurum Asker Hastanesi, Goz Hastaliklari Klin, TR-25080 Erzurum, Turkey
来源：
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2015年 / 253卷 / 05期
关键词：
Correlation Analysis; Visual Acuity; Slow Rate; Small Decrease; Ranibizumab;
D O I：
10.1007/s00417-014-2877-y
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：823 / 823
页数：1
相关论文
共 50 条
  • [31] A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration
    Park, Dae Hyun
    Sun, Hae Jung
    Lee, Sung Jin
    INTERNATIONAL OPHTHALMOLOGY, 2017, 37 (05) : 1205 - 1214
  • [32] Recommencing Intravitreal Ranibizumab Injections for Neovascular Age-Related Macular Degeneration in Patients Following Endophthalmitis
    Sharma, Hannah
    Routledge, Claire
    Elaraoud, Ibtesam
    Mitra, Arijit
    Mushtaq, Bushra
    Lip, Peck-Lin
    Elsherbiny, Samer
    OPHTHALMOLOGICA, 2016, 236 : 17 - 17
  • [33] Do Intravitreal Ranibizumab Injections for Wet Age-Related Macular Degeneration Affect the Vitreomacular Interface?
    Sreekantam, S.
    Gibson, J. M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [34] THE MACULAR HOLE AFTER INTRAVITREAL INJECTIONS OF RANIBIZUMAB IN A PATIENT WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION - A CASE STUDY
    Kal, Magdalena
    Biskup, Michal
    Mackiewicz, Jerzy
    MEDICAL STUDIES-STUDIA MEDYCZNE, 2013, 29 (01) : 89 - 93
  • [35] Treatment of neovascular age-related macular degeneration with Ranibizumab/LucentisTM
    Michels, S
    Rosenfeld, PJ
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2005, 222 (06) : 480 - 484
  • [36] Age-related macular degeneration: Analysis of the results of ranibizumab therapy
    Casaroli-Marano, Ricardo
    Adan, Alfredo
    Gomez-Ulla, Francisco
    Maria Diaz, Josep
    MEDICINA CLINICA, 2011, 136 (03): : 128 - 129
  • [37] Ranibizumab for the treatment of neovascular age-related macular degeneration: A review
    Kourlas, Helen
    Abrams, Paris
    CLINICAL THERAPEUTICS, 2007, 29 (09) : 1850 - 1861
  • [38] Ranibizumab and aflibercept for the treatment of wet age-related macular degeneration
    Yazdi, Mohammad Hossein
    Faramarzi, Mohammad All
    Nikfar, Shekoufeh
    Falavarjani, Khalil Ghasemi
    Abdollahi, Mohammad
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (09) : 1349 - 1358
  • [39] A safety evaluation of ranibizumab in the treatment of age-related macular degeneration
    Gibson, Jonathan Mark
    Gibson, Stewart James
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (09) : 1259 - 1270
  • [40] Systemic Vascular Safety of Ranibizumab for Age-Related Macular Degeneration
    Ueta, Takashi
    Noda, Yasuo
    Toyama, Taku
    Yamaguchi, Takuhiro
    Amano, Shiro
    OPHTHALMOLOGY, 2014, 121 (11) : 2193 - 2203
12345